Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer

References

• Zhao B, Du F, Xu P, et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature. 2019;569(7758):718–722.
   Web of Science ®Google Scholar
• Ahn J, Xia T, Konno H, et al. Inflammation-driven carcinogenesis is mediated through STING. 5(5166):2014.
   Google Scholar
• Oki E, Tokunaga S, Emi Y, et al. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2016;19(3):968–976.
   PubMed Web of Science ®Google Scholar
• Smyth E, Nilsson M, Grabsch H, et al. Gastric cancer. Lancet (London, England). 2020;396(10251):635–648.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Barber GJN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674–678.
   PubMed Web of Science ®Google Scholar
• Guey B, Wischnewski M, Decout A, et al. BAF restricts cGAS on nuclear DNA to prevent innate immune activation. Science (New York, N.Y.). 2020;369(6505):823–828.
   PubMed Web of Science ®Google Scholar
• Liu S, Cai X, Wu J, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science (New York, N.Y.). 2015;347(6227):aaa2630.
   PubMed Web of Science ®Google Scholar
• Grabosch S, Bulatovic M, Zeng F, et al. Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles. Oncogene. 2019;38(13):2380–2393.
   PubMed Web of Science ®Google Scholar
• Shen J, Zhao W, Ju Z, et al. PARPi triggers the sting-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness. Cancer Research. 2019;79(2):311–319.
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary Oncology (Poznan, Poland). 2015;19(1A):A68–77.
   PubMedGoogle Scholar
• NCBI. GEO: archive for functional genomics data sets-update.Nucleic Acids Research. 2013, 39(Database issue):1005–1010.
   Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : A Journal of Integrative Biology. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Research. 2017;77:e108.
   Google Scholar
• Am N, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 2015;12(5):453–457.
   PubMed Web of Science ®Google Scholar
• Dunn G, Dunn I, Curry W. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immunity. 2007;7:12.
   Google Scholar
• Barbie D, Tamayo P, Boehm J, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108–112.
   PubMed Web of Science ®Google Scholar
• Tan Y, Sansanaphongpricha K, Xie Y, et al. Mitigating SOX2-potentiated immune escape of head and neck squamous cell carcinoma with a sting-inducing nanosatellite vaccine. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. 2018;24(17):4242–4255.
   PubMed Web of Science ®Google Scholar
• Spranger S, Sivan A, Corrales L, et al. Tumor and host factors controlling antitumor immunity and efficacy of cancer immunotherapy. Advances in Immunology. 2016;130:75–93.
   PubMed Web of Science ®Google Scholar
• Qin X, Tao N, Dergay A, et al. Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(24):14411–14416.
   PubMed Web of Science ®Google Scholar
• Mr P, Jacobson BA, Ji Y, et al. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. Oncotarget. 2015;6.
   Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor perspectives in biology. 2014;6.
   Google Scholar
• Kesh K, Garrido V, Dosch A, et al. Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways. Cell Death & Disease. 2020;11(11):967.
   PubMed Web of Science ®Google Scholar
• AJAroi B. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology. 1996;14:649–683.
   Google Scholar
• Gang H, Qianjun W, Yongliang Z, et al. NF-KB plays a key role in inducing CD274 expression in human monocytes after lipopolysaccharide treatment. Plos One. 2013;8:e61602.
   Google Scholar
• Liu J, Wu W, Xie Y, et al. Overexpression of TRIM66 functions as an oncogene in lung cancer progression. 2016;9: 4966–4977.
   Google Scholar
• Suzuki, Research TJCC. Estrogen-responsive finger protein as a new potential biomarker for breast cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. 2005;11(17):6148–6154.
   PubMed Web of Science ®Google Scholar
• Research CC, Jj C, Yl R, Cj S, et al. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis. Journal of Experimental & Clinical Cancer Research. 2020;39.
   Google Scholar
• Thike A, Chen X, Koh V, et al. Higher densities of tumour-infiltrating lymphocytes and CD4 T cells predict recurrence and progression of ductal carcinoma in situ of the breast. Histopathology. 2020;76(6):852–864.
   PubMed Web of Science ®Google Scholar
• Han S, Zhang C, Li Q, et al. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. British Journal of Cancer. 2014;110(10):2560–2568.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Peng L, Zhao Y, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunology, Immunotherapy : CII. 2012;61(11):1965–1975.
   PubMed Web of Science ®Google Scholar
• Durgeau A, Virk Y, Corgnac S, et al. Recent advances in targeting CD8 T-Cell immunity for more effective cancer immunotherapy. Frontiers in immunology. 2018;9:14.
   Google Scholar
• Griss J, Bauer W, Wagner C, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nature Communications. 2019;10(1):4186.
   PubMedGoogle Scholar
• Fu Q, Chen N, Ge C, et al. Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis. OncoImmunology. 2019;8:1–14.
   Google Scholar
• Gambardella V, Castillo J, Tarazona N, et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treatment Reviews. 2020;86:102015.
   PubMed Web of Science ®Google Scholar